NICE approves Forxiga, new diabetes treatment from Bristol-Myers Squibb and Astrazeneca

May 30, 2013 | By Márcio Barra

NICE, the UK price regulatory agency, gave yesterday their final positive evaluation for Bristol-Myers Squibb and Astrazeneca’s new diabetes drug Forxiga (dapagliflozin), a new, first in class treatment for type II diabetes, allowing it’s commercialization in the UK.

The drug was first approved by the European Medicines Agency (EMA) back in November 2012, but NICE requested more information from the manufacturers, and asked its Decision Support Unit to conduct an in-depth review of the economic analysis provided by the manufacturer, alongside an exploratory analysis of the drug in dual therapy and as an add-on to Insulin. The drug wasn’t approved in the USA due to cardiovascular concerns expressed by the FDA.

NICE’s approval and draft guidance recommend Forxiga as a dual-therapy drug for patients with type II diabetes, either in combination with metformin, or with insulin. It’s not recommended as part of a triple-drug regimen (Forxiga + Metformin + Insulin). The approval also recommends the use of Forxiga alongside Metformin when a sulphonylurea can’t be used. Moreover, combining Forxiga with metformin may be preferable to a thiazolidinedione if further weigh gain is a concern.

Forxiga is a drug with a novel first-in-class mode of action. It works by inhibiting the subtype 2 of the sodium-glucose transport proteins, responsible for 90% of glucose reabsorption in the kidney, effectively pushing blood glucose out of the body through the kidneys.

Final guidance from NICE is expected in June.

Sources:

NICE

1 comment
  1. Admiring the time and effort you put into your site and in depth information you provide.
    It’s good to come across a blog every once in a while that isn’t the same
    unwanted rehashed material. Great read! I’ve saved your site and I’m adding your
    RSS feeds to my Google account.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: